Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 07, 2022 02:00 ET | Source: Open Society Foundations

New Gavi Risk Sharing Partnership with MedAccess and the Open Society Foundations to help meet country demand for COVID-19 vaccines

New York, April 07, 2022 (GLOBE NEWSWIRE) -- Gavi, MedAccess, and the Open Society Foundations announce a new partnership to create an innovative Risk Sharing Facility to support the COVAX...
July 27, 2021 08:20 ET | Source: Dyadic International, Inc.

Dyadic Announces Technology Transfer and Licensing Agreement With South Africa’s Rubic Consortium Aiming to Develop and Commercialize Vaccines for Distribution Throughout the African Continent

Arrangement includes C1 COVID-19 vaccine technology transfer and licensing agreementProvides potential funding pathway for a C1 manufactured COVID-19 vaccine to progress through Phase II and Phase III...
July 07, 2021 06:32 ET | Source: Hatch Ltd

Hatch raises C$1 million for COVAX and UNICEF

Mississauga, Canada, July 07, 2021 (GLOBE NEWSWIRE) -- Mississauga, Canada— Hatch employees came together in an eight-week-long campaign to raise funds in support of COVAX, helping them progress...
May 27, 2021 08:30 ET | Source: UNICEF Canada

Canadian business and philanthropic leaders call on their peers to #ShareTheHealth and donate to UNICEF’s COVID-19 Global Vaccination Efforts

Toronto, Ontario, May 27, 2021 (GLOBE NEWSWIRE) -- Today, 16 senior leaders from top Canadian companies and foundations, including Teck Resources Limited and Fairmount Foundation, released an Open...
March 04, 2021 00:00 ET | Source: UPS

UPS Healthcare and The UPS Foundation make financial and in-kind commitment to facilitate equitable worldwide vaccine deliveries

Initial commitment for delivery of 20 million doses to countries in need across four continentsKey support for equitable vaccine distribution through COVAX, Gavi, the vaccine alliance and CARE’s Fast...
January 22, 2021 12:00 ET | Source: BioNTech SE

Pfizer und BioNTech erzielen Vereinbarung mit COVAX für Vorabkauf von Impfstoff zur Bekämpfung von COVID-19

Initiale Vereinbarung über Bereitstellung von bis zu 40 Millionen Impfstoffdosen an die COVAX-Initiative im Jahr 2021Erste Lieferungen sollen im ersten Quartal 2021 beginnen, vorbehaltlich der...
January 22, 2021 12:00 ET | Source: BioNTech SE

Pfizer and BioNTech Reach Agreement with COVAX for Advance Purchase of Vaccine to Help Combat COVID-19

Initial agreement provides up to 40 million doses to COVAX in 2021First deliveries are expected to take place in Q1 2021 subject to the execution of supply agreements under the COVAX Facility...